Beijing Scitop Bio-tech Co., Ltd. Class ASZSE: 300858

Beijing Scitop Bio-tech Co: Revenue up 18.32% YoY, net profit down 5.31% amid capacity investment and strong microecological growth

· Issued by Beijing Scitop Bio-tech Co., Ltd. Class A

Revenue grew 18.32% year-over-year to ¥163.35 million, but net profit declined 5.31% to ¥41.21 million due to higher depreciation and investment in new capacity. Animal and plant microecological products saw strong growth, while the company continued to invest in R&D and production expansion.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

Earlier from Beijing Scitop Bio-tech Co., Ltd. Class A

All Beijing Scitop Bio-tech Co., Ltd. Class A news releases